Assignee
BEVEC DORIAN
DE·5 granted patents·75 pending applications·3 citations·filing 2002–2022
Top patents by PatentIndex Score
80 records- 0170US9044426B2Antimicrobial peptides for treatment of infectious diseasesBEVEC DORIAN·Filed 2012·Granted Jun 2, 2015·1 cites·39 claims
- 0270US2010190713A1Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0370US2010204140A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0470US2010184708A1Use of gly-pro-glu-oh (gpe) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0570US2010204111A1Astressin and beta- endorphin for use as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0670US2010234306A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0770US2010197585A1Use of a rgd-peptide and/or parathyroid hormone (1-34) as anti-hiv agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0870US2010184698A1Use of a deslorelin and mastoparan as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0970US2010204155A1Use of the peptide sfllr-oh and muramyl dipeptide as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1068US8211856B2Use of somatostatin-14 as a therapeutic agentBEVEC DORIAN·Filed 2008·Granted Jul 3, 2012·1 cites·3 claims
- 1168US8193149B2Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicineBEVEC DORIAN·Filed 2008·Granted Jun 5, 2012·1 cites·4 claims
- 1265US2010210553A1Use of the peptide asn-asp-asp-cys-glu- leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu alone or in combination with the peptide thr-thr-ser-gln-val- arg-pro-arg as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1365US2010184675A1Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1463US2010184704A1Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1563US2010210532A1Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1663US2010210562A1Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1763US2010210558A1Minigastrin as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1863US2010184677A1Use of the human pancreatic polypeptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1963US2010190716A1Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2063US2010273701A1Use of salusin beta alone or in combination with octreotide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2163US2010190711A1Big gastrin i as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2263US2010204130A1Use of human neuropeptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2363US2010173845A1Use of fertirelin and delta-endorphin as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2463US2010204115A1Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2563US2010210536A1Use of leptin (22-56 ) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2663US2010197601A1Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infectionBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2763US2010197608A1Use of melanotrophin-potentiating factor as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2862US2010184679A1Use of a combination of cart peptides as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2962US2010204135A1Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s)BEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3062US2010204138A1Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3162US2010197603A1Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infectionsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3262US2010204150A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3362US2010204132A1THERAPEUTIC USES OF PEPTIDES YSAYPDSVPMMS and WMNSTGFTKVCGAPPCBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3462US2010204112A1Use of tyr-w-mif-1 and urocortin 2 as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3562US2010210535A1Therapeutic use of neuropeptide ei and acth 7-38 and compositions thereofBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3662US2010216724A1Use of fibronectin fragment (196-203 ) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3762US2010210555A1Use of a laminin peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3862US2010204142A1Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3961US2010210554A1Therapeutic uses of gastrin- 1 and g- pen-grgdspcaBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4061US2010210557A1Use of rfrp, alone or in combination with neurokinin-b, as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4161US2010204156A1Use of thymopentin as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4261US2010197602A1Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infectionBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4361US2010184673A1Use of parathyroid hormone ( 1-34 ) as anti-hiv agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4460US2010204116A1Use of calcitonin as anti-angiogenic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4560US2010197605A1Therapeutic use of peptide yglf and combination with kvlpvpqBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4660US2010204157A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4760US2010197586A1Use of secretin and optionally urodilatin as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4860US2010184674A1Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4960US2010197599A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 5060US2010204152A1Use of gluten exorphin c : as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →